Galal El‐Gazzaz
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Liver Disease and Transplantation 5
- Surgery top 5%
- Anorectal Disease Treatments and Outcomes 10
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Diverticular Disease and Complications 7
- Organ Transplantation Techniques and Outcomes 4
- Oncology top 10%
- Colorectal Cancer Surgical Treatments 4
- Rheumatology top 5%
- Pelvic floor disorders treatments 8
- Co-authors
- Tracy L. HullRavi P. KiranMassarat ZutshiFeza H. RemziJon D. VogelIan C. LaveryFederico AucejoJeffery Hammel
- Cited by
- HepatologySurgeryOncology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesUnited KingdomEgypt
In The Last Decade
Galal El‐Gazzaz
35 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 73
- Hepatology 382
- Surgery 782
- Oncology 397
- Rheumatology 196
- Epidemiology 195
Countries citing papers authored by Galal El‐Gazzaz
This map shows the geographic impact of Galal El‐Gazzaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galal El‐Gazzaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galal El‐Gazzaz more than expected).
Fields of papers citing papers by Galal El‐Gazzaz
This network shows the impact of papers produced by Galal El‐Gazzaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galal El‐Gazzaz. The network helps show where Galal El‐Gazzaz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Galal El‐Gazzaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2013 | 22 | |
| 3 | 2013 | 28 | |
| 4 | 2012 | 69 | |
| 5 | Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center. | 2012 | 2 |
| 6 | Serum Vascular Endothelial Growth Factor Level in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Experience of a Single Western Center | 2012 | 2 |
| 7 | 2012 | 48 | |
| 8 | 2012 | 16 | |
| 9 | 2012 | 19 | |
| 10 | 2012 | 21 | |
| 11 | 2011 | 24 | |
| 12 | 2010 | 11 | |
| 13 | 2010 | 19 | |
| 14 | 2010 | 39 | |
| 15 | 2009 | 25 | |
| 16 | 2009 | 31 | |
| 17 | 2009 | 39 | |
| 18 | 2009 | 45 | |
| 19 | 2000 | 58 | |
| 20 | 1998 | 19 |
About Galal El‐Gazzaz
Galal El‐Gazzaz is a scholar working on Hepatology, Surgery and Rheumatology, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Anorectal Disease Treatments and Outcomes (10 papers), Pelvic floor disorders treatments (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Diverticular Disease and Complications (7 papers), Liver Disease and Transplantation (5 papers), Colorectal Cancer Surgical Treatments (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). The work is most often cited by research in Hepatology (382 citations), Surgery (782 citations) and Oncology (397 citations). Galal El‐Gazzaz has collaborated with scholars based in United States, United Kingdom and Egypt. Frequent co-authors include Tracy L. Hull, Ravi P. Kiran, Massarat Zutshi, Feza H. Remzi, Jon D. Vogel, Ian C. Lavery, Federico Aucejo, Jeffery Hammel, P McMaster and James M. Church. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.